• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发进展型临床病程在视神经脊髓炎中并不常见。

A secondary progressive clinical course is uncommon in neuromyelitis optica.

作者信息

Wingerchuk D M, Pittock S J, Lucchinetti C F, Lennon V A, Weinshenker B G

机构信息

Department of Neurology, Mayo Clinic College of Medicine, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.

出版信息

Neurology. 2007 Feb 20;68(8):603-5. doi: 10.1212/01.wnl.0000254502.87233.9a.

DOI:10.1212/01.wnl.0000254502.87233.9a
PMID:17310032
Abstract

We compared the clinical course of 96 patients with neuromyelitis optica (NMO) to multiple sclerosis (MS) natural history data. Based on the distribution of follow-up data (median 6.1 year), we estimated that 21 NMO patients would convert to a secondary progressive course, but we observed only two conversions (p = 0.00002; relative risk = 0.08). The disparate natural histories of MS and NMO suggest dissociation between relapses and clinical progression in CNS demyelinating diseases.

摘要

我们将96例视神经脊髓炎(NMO)患者的临床病程与多发性硬化症(MS)的自然史数据进行了比较。根据随访数据的分布(中位数为6.1年),我们估计21例NMO患者会转变为继发进展型病程,但我们仅观察到2例转变(p = 0.00002;相对风险 = 0.08)。MS和NMO不同的自然史表明,中枢神经系统脱髓鞘疾病的复发与临床进展之间存在分离。

相似文献

1
A secondary progressive clinical course is uncommon in neuromyelitis optica.继发进展型临床病程在视神经脊髓炎中并不常见。
Neurology. 2007 Feb 20;68(8):603-5. doi: 10.1212/01.wnl.0000254502.87233.9a.
2
Devic's neuromyelitis optica in an infant case.婴儿期的视神经脊髓炎谱系疾病病例
J Child Neurol. 2007 Sep;22(9):1143-6. doi: 10.1177/0883073807306270.
3
Neuromyelitis optica preceded by hyperCKemia episode.神经肌髓炎视神经病变之前有高肌酸激酶血症发作。
Neurology. 2010 May 11;74(19):1543-5. doi: 10.1212/WNL.0b013e3181dd445b.
4
Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.伴有脊髓炎的局限性视神经脊髓炎的病理和免疫特征
Neurology. 2009 Nov 17;73(20):1628-37. doi: 10.1212/WNL.0b013e3181c1deb9.
5
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.视神经脊髓炎病灶中aquaporin 4的缺失:与多发性硬化的鉴别。
Brain. 2007 May;130(Pt 5):1224-34. doi: 10.1093/brain/awm047. Epub 2007 Apr 2.
6
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.临床孤立综合征提示多发性硬化时的视神经脊髓炎诊断。
Neurology. 2006 May 23;66(10):1568-70. doi: 10.1212/01.wnl.0000216233.56611.c2.
7
Neuromyelitis optica: effect of gender.视神经脊髓炎:性别影响
J Neurol Sci. 2009 Nov 15;286(1-2):18-23. doi: 10.1016/j.jns.2009.08.045. Epub 2009 Sep 8.
8
Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.视神经脊髓炎:一种中枢神经系统独特的脱髓鞘疾病。
Acta Neurol Scand. 2008 Oct;118(4):209-17. doi: 10.1111/j.1600-0404.2008.01002.x. Epub 2008 Mar 11.
9
Neuromyelitis optica and concentric rings of Baló in the brainstem.视神经脊髓炎与脑干中的巴洛同心环病变。
Arch Neurol. 2009 Feb;66(2):274-5. doi: 10.1001/archneurol.2008.539.
10
NMO-IgG and Devic's neuromyelitis optica: a French experience.视神经脊髓炎免疫球蛋白(NMO-IgG)与德维克视神经脊髓炎:法国的经验
Mult Scler. 2008 May;14(4):440-5. doi: 10.1177/1352458507084595. Epub 2008 Jan 21.

引用本文的文献

1
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.视神经脊髓炎谱系疾病(NMOSD)患者血清中芳烃受体血浆激动剂活性水平降低,且与疾病活动度相关。
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200457. doi: 10.1212/NXI.0000000000200457. Epub 2025 Aug 5.
2
Distinct prognostic implications of blood neuronal and astroglial biomarkers in neuromyelitis optica spectrum disorders versus multiple sclerosis.视神经脊髓炎谱系障碍与多发性硬化症中血液神经元和星形胶质细胞生物标志物的不同预后意义。
Sci Rep. 2025 Apr 2;15(1):11326. doi: 10.1038/s41598-025-95773-6.
3
AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD.
在视神经脊髓炎谱系障碍(NMOSD)模型中,水通道蛋白4(AQP4)特异性T细胞决定了中枢神经系统(CNS)中的病变定位。
Acta Neuropathol Commun. 2025 Feb 11;13(1):27. doi: 10.1186/s40478-025-01947-8.
4
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders.迈向治疗视神经脊髓炎谱系疾病的新时代。
J Neurol. 2024 Jul;271(7):3879-3896. doi: 10.1007/s00415-024-12426-w. Epub 2024 May 21.
5
CD11c B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica.CD11c+B 细胞扩增与视神经脊髓炎的严重程度和脑萎缩相关。
Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200206. doi: 10.1212/NXI.0000000000200206. Epub 2024 Feb 13.
6
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.视神经脊髓炎谱系疾病(NMOSD)的诊断和治疗进展——视神经脊髓炎研究组(NEMOS)的修订建议。第二部分:发作期治疗和长期管理。
J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7.
7
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review.模拟和误诊为 NMOSD 的非脱髓鞘疾病:文献综述。
Eur J Neurol. 2023 Oct;30(10):3367-3376. doi: 10.1111/ene.15983. Epub 2023 Jul 19.
8
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.血清神经丝轻链水平在发作时预测发作后残疾恶化,并被依鲁替尼减轻:视神经脊髓炎谱系障碍中四个潜在生物标志物的分析。
J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):757-768. doi: 10.1136/jnnp-2022-330412. Epub 2023 May 23.
9
A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder.单次复发会导致视神经脊髓炎谱系障碍患者的残疾状况恶化以及与健康相关的生活质量下降。
Front Neurol. 2023 Apr 11;14:1099376. doi: 10.3389/fneur.2023.1099376. eCollection 2023.
10
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity.MOGAD 患者自身抗体诱导补体、吞噬作用和细胞细胞毒性。
JCI Insight. 2023 Jun 8;8(11):e165373. doi: 10.1172/jci.insight.165373.